10x Genomics, Inc.
NASDAQ:TXG
9.88 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 610.785 | 618.727 | 516.409 | 490.49 | 298.845 | 245.893 | 146.313 | 71.085 |
| Cost of Revenue
| 196.303 | 209.414 | 120.386 | 74.091 | 58.468 | 61.033 | 28.661 | 10.56 |
| Gross Profit
| 414.482 | 409.313 | 396.023 | 416.399 | 240.377 | 184.86 | 117.652 | 60.525 |
| Gross Profit Ratio
| 0.679 | 0.662 | 0.767 | 0.849 | 0.804 | 0.752 | 0.804 | 0.851 |
| Reseach & Development Expenses
| 264.698 | 270.332 | 265.667 | 211.752 | 123.375 | 83.097 | 47.537 | 32.164 |
| General & Administrative Expenses
| 0 | 340.03 | 294.6 | 252.86 | 200.426 | 129.334 | 87.236 | 46.536 |
| Selling & Marketing Expenses
| 0 | 3.3 | 3.7 | 4.7 | 1.9 | 1.5 | 0.7 | 0.2 |
| SG&A
| 344.343 | 343.33 | 298.3 | 257.56 | 202.326 | 130.834 | 87.936 | 46.736 |
| Other Expenses
| 0 | 0 | -0.198 | -0.802 | 1.337 | -0.186 | -0.249 | 0.137 |
| Operating Expenses
| 609.041 | 674.949 | 563.967 | 469.312 | 325.701 | 213.931 | 135.473 | 78.9 |
| Operating Income
| -194.559 | -194.949 | -167.944 | -52.913 | -85.324 | -29.071 | -110.764 | -18.375 |
| Operating Income Ratio
| -0.319 | -0.315 | -0.325 | -0.108 | -0.286 | -0.118 | -0.757 | -0.258 |
| Total Other Income Expenses Net
| 16.859 | -53.814 | 5.973 | -0.802 | -449.152 | -1.962 | -1.634 | -0.366 |
| Income Before Tax
| -177.7 | -248.763 | -161.971 | -53.715 | -534.476 | -31.033 | -112.398 | -18.741 |
| Income Before Tax Ratio
| -0.291 | -0.402 | -0.314 | -0.11 | -1.788 | -0.126 | -0.768 | -0.264 |
| Income Tax Expense
| 4.927 | 6.336 | 4.029 | 4.508 | 8.255 | 0.218 | 0.087 | 0.021 |
| Net Income
| -182.627 | -255.099 | -166 | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Net Income Ratio
| -0.299 | -0.412 | -0.321 | -0.119 | -1.816 | -0.127 | -0.769 | -0.264 |
| EPS
| -1.52 | -2.18 | -1.46 | -0.53 | -5.37 | -0.8 | -8.4 | -1.62 |
| EPS Diluted
| -1.52 | -2.18 | -1.46 | -0.53 | -5.37 | -0.8 | -8.4 | -1.62 |
| EBITDA
| -133.988 | -205.111 | -128.489 | -24.595 | -513.773 | -20.888 | -106.084 | -13.625 |
| EBITDA Ratio
| -0.219 | -0.332 | -0.313 | -0.109 | -0.276 | -0.108 | -0.09 | -0.192 |